William Martin Carrera MD

Ophthalmology•Oakland, CA

Retinal Disease

Physician

Join to View Full Profile

3300 Telegraph AveOakland, CA 94609
Phone+1 510-444-1600
Fax+1 510-444-5117

Education & Training

Tufts Medical CenterFellowship, Surgical Retina and Vitreous, 2022 - 2024
Sutter Health/California Pacific Medical CenterResidency, Ophthalmology, 2019 - 2022
Wake Forest University Baptist Medical CenterInternship, Internal Medicine, 2017 - 2018
Case Western Reserve University School of MedicineClass of 2017
Georgetown UniversityMS, Physiology and Biophysics, 2012 - 2013
University of ChicagoBA, Biology, History, with Honors

Certifications & Licensure

CA State Medical License 2018 - 2026
MA State Medical License 2022 - 2025
NC State Medical License 2017 - 2018
American Board of Ophthalmology Ophthalmology

Clinical Trials

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD Start of enrollment: 2021 Mar 04
ACTIVE_NOT_RECRUITING
PHASE3
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy Start of enrollment: 2021 Feb 26
COMPLETED
PHASE2
A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) Start of enrollment: 2020 Jun 22
COMPLETED
PHASE3
FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD Start of enrollment: 2018 Dec 17
TERMINATED
PHASE1, PHASE2
A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) Start of enrollment: 2021 Jun 23
COMPLETED
PHASE3
Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye Start of enrollment: 2020 Aug 11
COMPLETED
PHASE3
Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease Start of enrollment: 2020 Jun 29
COMPLETED
PHASE2, PHASE3
A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME) Start of enrollment: 2020 Sep 30
TERMINATED
PHASE3
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema Start of enrollment: 2020 Aug 05
COMPLETED
PHASE3
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD Start of enrollment: 2020 Dec 29
RECRUITING
PHASE2, PHASE3
Extension Study for the Port Delivery System With Ranibizumab (Portal) Start of enrollment: 2018 Sep 20
RECRUITING
PHASE3
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion Start of enrollment: 2021 Mar 02
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

A 19-year-old asymptomatic woman.
William Carrera, Michelle C Liang
Retinal Cases & Brief Reports. 2025-01-14
Multimodal imaging in deferasirox-mediated retinopathy.
Jonathan Caranfa, William Carrera, Anna Marmalidou, Shilpa Desai, Caroline Baumal
European Journal of Ophthalmology. 2024-07-01
CLINICAL AND STRUCTURAL IMPACT OF SUBMACULAR FLUID AFTER PNEUMATIC RETINOPEXY REPAIR FOR RHEGMATOGENOUS RETINAL DETACHMENT.
William M Carrera, Michelle Y Peng, Manisha Reddy, Judy J Chen, Robert N Johnson
Retina. 2023-01-01